Tower Research Capital »

Caris Life Sciences shares owned by Tower Research Capital

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $696 23 30.26
2025-06-30 $56k 2.1k 26.72

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Caris Life Sciences

Sixth Street Partners Management Company
Coatue Management
FMR
T. Rowe Price Investment Management
Braidwell
Silver Lake Group
Neuberger Berman Group
Millennium Management
PointState Capital
OrbiMed Advisors
Ameriprise Financial
ClearBridge Advisors
Canada Pension Plan Investment Board
Alliancebernstein
Ubs Global Asset Management Americas

View all funds holding Caris Life Sciences